Register for email alerts and news feeds:
This journal | BMJ Group
rss
Tobacco Control 2005;14:193-200; doi:10.1136/tc.2004.009878
Copyright © 2005 by the BMJ Publishing Group Ltd.
Tobacco Control 2005;14:193-200
© 2005 BMJ Publishing Group Ltd

RESEARCH PAPER

Understanding Philip Morris’s pursuit of US government regulation of tobacco

P A McDaniel1, R E Malone2

1 Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California, USA
2 Department of Social and Behavioral Sciences, School of Nursing, University of California, San Francisco

Correspondence to:
Correspondence to:
Patricia A McDaniel
PhD, Center for Tobacco Control Research and Education, University of California, San Francisco, 530 Parnassus Avenue, Suite 366, San Francisco, CA 94143-1390, USA; pmcdanie{at}itsa.ucsf.edu

Objective: To investigate Philip Morris’s support of US Food and Drug Administration (FDA) regulation of tobacco products and analyse its relationship to the company’s image enhancement strategies.

Data sources: Internal Philip Morris documents released as part of the Master Settlement Agreement.

Methods: Searches of the Legacy Tobacco Documents Library (http://legacy.library.ucsf.edu) beginning with such terms as "FDA" and "regulatory strategy" and expanding to include relevant new terms.

Results: Philip Morris’s support for government regulation of tobacco is part of a broader effort to address its negative public image, which has a damaging impact on the company’s stock price, political influence, and employee morale. Through regulation, the company seeks to enhance its legitimacy, redefine itself as socially responsible, and alter the litigation environment. Whereas health advocates frame tobacco use as a public health policy issue, Philip Morris’s regulatory efforts focus on framing tobacco use as an individual choice by informed adults to use a risky product. This framing allows Philip Morris to portray itself as a reasonable and responsible manufacturer and marketer of risky products.

Conclusions: Philip Morris’s ability to improve its image through support of FDA regulation may undermine tobacco control efforts aimed at delegitimising the tobacco industry. It may also create the impression that Philip Morris’s products are being made safer and ultimately protect the company from litigation. While strong regulation of tobacco products and promotion remain critical public health goals, previous experiences with tobacco regulation show that caution may be warranted.

Abbreviations: ACS, American Cancer Society; AHA, American Heart Association; ALA, American Lung Association; CTFK, Campaign for Tobacco-Free Kids; FCLAA, Federal Cigarette Labeling and Advertising Act; FDA, Food and Drug Administration; MSA, Master Settlement Agreement; NCI, National Cancer Institute; PM, Philip Morris

Keywords: Philip Morris; Food and Drug Administration regulation; FDA regulation; corporate image enhancement


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • McDaniel, P. A., Malone, R. E. (2009). The Role of Corporate Credibility in Legitimizing Disease Promotion. AJPH 99: 452-461 [Abstract] [Full Text]  
  • Tesler, L. E., Malone, R. E. (2008). Corporate Philanthropy, Lobbying, and Public Health Policy. AJPH 98: 2123-2133 [Abstract] [Full Text]  
  • Yang, J S, Malone, R E (2008). "Working to shape what society's expectations of us should be": Philip Morris' societal alignment strategy. Tobacco Control 17: 391-398 [Abstract] [Full Text]  
  • Malone, R. E (2007). Working to make a disease. Tobacco Control 16: 361-362 [Full Text]  
  • Givel, M. (2007). FDA legislation. Tobacco Control 16: 217-218 [Full Text]  
  • Anderson, S. J, Ling, P. M, Glantz, S. A (2007). Implications of the federal court order banning the terms "light" and "mild": what difference could it make?. Tobacco Control 16: 275-279 [Abstract] [Full Text]  
  • Balbach, E. D, Smith, E. A, Malone, R. E (2006). How the health belief model helps the tobacco industry: individuals, choice, and "information". Tobacco Control 15: iv37-iv43 [Abstract] [Full Text]  
  • McDaniel, P A, Smith, E A, Malone, R E (2006). Philip Morris's Project Sunrise: weakening tobacco control by working with it. Tobacco Control 15: 215-223 [Abstract] [Full Text]  

eLetters:

Read all eLetters

Time for society to redefine "reasonable"
John R. Polito
Tobacco Control Online, 4 Jun 2005 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.